SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes

P L Weistroffer1, S Joly, R Srikantha

  • 1Department of Periodontics, College of Dentistry, University of Iowa, Iowa City, IA 52242, USA.

Abstract

Insights

Sheep cathelicidins SMAP29 and SMAP28 show potent antimicrobial activity against oral bacteria. Their congeners may offer a novel alternative for treating periodontal diseases with minimal toxicity.

Area of Science:

  • Antimicrobial Peptides
  • Oral Microbiology
  • Biochemistry

Background:

  • Cathelicidins are crucial antimicrobial peptides in host defense.
  • SMAP29, a sheep cathelicidin, exhibits antimicrobial properties against oral pathogens.
  • This study investigates SMAP29, SMAP28, and related congeners.

Purpose of the Study:

  • To evaluate the antimicrobial efficacy of SMAP29, SMAP28, and congeners against oral bacteria.
  • To assess the cytotoxicity of these peptides on keratinocytes.

Main Methods:

  • Radial diffusion assay to determine antimicrobial activity against key oral bacteria.
  • Lactate dehydrogenase release assay to measure keratinocyte cytotoxicity.

Main Results:

  • SMAP28 demonstrated the highest antimicrobial potency, with activity strongly correlated with SMAP29.
  • Congeners also showed antimicrobial effects, with varying efficacy against different bacterial strains.
  • Cytotoxicity was dose- and length-dependent, with SMAP14A being the least toxic.

Conclusions:

  • SMAP29 congeners exhibit significant antimicrobial activity against oral microorganisms.
  • Minimal observed toxicity suggests potential as alternatives to traditional antibiotics for oral diseases.
  • These findings support the development of cathelicidin-based therapies for periodontal conditions.